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ABSTRACT OF THESIS

INFLUENCE OF TISSUE ABSORPTION AND SCATTERING ON
DIFFUSE CORRELATION SPECTROSCOPY BLOOD FLOW MEASUREMENTS
This investigation evaluates the influences of optical property assumptions on nearinfrared diffuse correlation spectroscopy (DCS) flow index measurements. Independent
variation is induced in optical properties, absorption coefficient (μa) and reduced
scattering coefficient (μs’), of liquid phantoms with concurrent measurements of flow
indices. A hybrid instrument is incorporated consisting of a dual-wavelength (785 and
830 nm) DCS flow device to obtain flow indices and a frequency-domain tissue-oximeter
for optical properties. Flow indices are calculated with measured μa and μs’ or assumed
constant μa and μs’. Inaccurate μs’ assumptions produced much larger flow index errors
than inaccurate μa. Underestimated/overestimated μs’ from -35%/+175% lead to flow
index errors of +110%/-80% and underestimated/overestimated μa from -40%/+150%
lead to -20%/+40%, regardless of wavelength. Analysis of a clinical study involving
human head and neck tumors indicates flow index errors due to inter-patient optical
property variations up to +280%. Collectively, these findings suggest that studies
involving significant μa and μs’ changes should measure flow index and optical properties
simultaneously to accurately extract blood flow information. This study provides unique
insight through the use of liquid phantoms, hybrid instrumentation, incorporation of
measurement errors and a generalization into DCS flow index errors due to the influences
of optical properties.
KEYWORDS: Diffuse Correlation Spectroscopy, Diffusing Wave Spectroscopy, Near
Infrared Spectroscopy, Tissue Optical Properties, Blood Flow
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CHAPTER 1: INTRODUCTION

1.1 Blood Flow Measurements

Blood flow is widely used as a physiological parameter in the assessment of multiple
facets of disease including diagnosis [1] and treatment efficacies [2]. Analyses of blood
flow extend into many applications. For example, the identification of blood flow
abnormalities may be investigated for diseases such as peripheral arterial disease (PAD)
[3]. The increase or decrease of blood flow to ischemic muscle tissue after surgical
techniques can provide useful information as to the success of the procedures [3].
Monitoring blood flow may reveal benefits of particular treatment methods which are
very important in studies involving tumors [1, 2, 4]. The tumor blood flow response to
applications of radiation treatment to subjects with tumors can reveal if the treatment is
working [2, 4]. The tumor site may also potentially be identified through exhibition of
blood flow different from that of surrounding tissues [1]. Blood flow responses may also
be followed after induced stimuli to examine activity of the brain [5].
In practice, blood flow measurements can be achieved through a variety of
noninvasive technologies. Each has their own advantages and disadvantages and thus
many factors must be considered including costs, portability, subject anatomy, accuracy,
data acquisition time, and sensitivity. Sensitivity concerns the differentiation between
vessels of varying sizes from large, such as arteries, to small such as capillaries. For
superficial blood flow measurements (several μm to mm), technologies such as laser
Doppler flowmetry (LDF) [6-8], optical microangiography (OMAG) [9], Doppler optical
coherence tomography (DOCT) [10], and photoacoustic tomography (PAT) [11] may be
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utilized. Penetration into deep tissues (e.g., several centimeters) is a limitation of
employing these methods. Several modalities exist capable of penetrating into deep
tissues such as Xenon-enhanced computed tomography (Xe-CT) and positron emission
tomography (PET). While these are predominantly sensitive to microvasculature, they
require the need for undesirable exposure to effects such as radiation. The applicability of
using these deep penetration devices bedside is limited due to high costs and low
portability. A new technology, near-infrared (NIR) diffuse correlation spectroscopy
(DCS), has sought to fill some of the gaps in deep tissue microvasculature blood flow
measurements by means of low cost, noninvasive, fast and portable instrumentation.

1.2 Near Infrared Diffuse Optical Techniques

Our investigations involve the use of NIR light to probe deep tissues. NIR light is
employed in biomedical applications due to the discovery of a spectral (600 – 900 nm)
window (see Fig. 1) in biological tissues [12]. This window allows deep penetration due
to the low tissue absorption. Diffuse optical systems can be utilized for the extraction of
information including tissue optical properties, oxygenated hemoglobin concentration
(HbO2), deoxygenated hemoglobin concentration (Hb), and blood flow [12, 13]. Note
that tissue optical properties are represented by the absorption coefficient, μa (cm-1 units),
and reduced scattering coefficient, μs’ (cm-1 units). We will refer to diffuse optical
equipment measuring μa, μs’, HbO2, and Hb as NIR spectroscopy (NIRS) and blood flow
as DCS.
Typically, NIRS is separated into three paradigms: time-domain (TD) (additionally
known as time-resolved spectroscopy, TRS), frequency-domain (FD), and continuous-
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wave (CW). TD systems use light pulses and contain high information content but are
expensive and complex [12, 13]. Modulated light from FD systems provide less
information content than TD systems but are capable of separating μa and μs’ and
obtaining Hb and HbO2 [12, 13]. The final paradigm employs a CW light source and is
generally inexpensive and simple in comparison to the TD and FD paradigms. However,
CW light provides limited information content making it difficult to decouple tissue
optical properties [12, 13]. In this study we are only concerned with absolute μa and μs’
from FD NIRS measurements.

Figure 1. Spectral Window
The wavelength-dependent absorption coefficients (μa) shown for oxygenated hemoglobin (HbO2),
deoxygenated hemoglobin (Hb), and water (H2O) with the NIR spectral window denoted with dashed lines
for the wavelength range of 600 – 900 nm.

For NIRS measurements, a pair of source and detector optical fibers is placed on the
tissue surface separated by a distance of up to a few centimeters. An NIR laser emits light
3

into tissue through the source fiber. Photon migrates in the tissue following a well-known
diffusive process before being detected by a photodetector connected to the detector fiber
[12, 14]. The tissue optical properties, μa and μs’, represent the reciprocals of absorption
and scattering length, respectively. The absorption length describes the distance a photon
travels before encountering an absorption event and similarly for the scattering length
corresponding to a scattering event. Note that the optical properties are wavelength, λ,
dependent, i.e., μa (λ) and μs’ (λ), but are written without the dependence notation
throughout this paper. Light scattering in biological tissues is generally much greater than
that of absorption resulting in diffusive behavior.
For the determination of particle dynamics (flow), speckle fluctuations in scattered
light intensity are monitored [12, 13]. Previous success in flow measurements (e.g., laser
Doppler) has been obtained in optically thin samples where single scattering photon
correlation spectroscopy (PCS) can be assumed [13, 15, 16]. In probing the motions in
thick/deep tissues, however, additional complications are encountered. Such optically
thick tissue samples result in multiple scattering and randomization of light propagation.
To address this multiple scattering problem DCS [14, 15, 17, 18], also known as diffusing
wave spectroscopy (DWS) [5, 19], has been developed that takes advantage of the
diffusive behavior of light as it propagates through the tissue.

1.3 Diffuse Correlation Spectroscopy (DCS)

DCS flow measurements are performed from the surface of the tissue region of
interest, similar to NIRS. The flow measurements are obtained by monitoring the time
autocorrelation function of speckle fluctuations detected at the photodetector. To

4

accomplish this, a long coherence length CW NIR laser is employed to provide a constant
phase both spatially and temporally [12, 14, 16]. Speckle fluctuations in non-muscular
biological tissues are primarily due to the movement of red blood cells (RBC’s) in vessels
[1, 2, 4, 5, 12, 18, 20-38]. However, motion artifacts and tissue shearing may arise in
muscular tissues which may complicate measurements [39, 40]. DCS produces a blood
flow index (BFI) and subsequent relative blood flow (rBF) from those fluctuations. The
rBF produced from DCS measurements has been validated against other technologies in
many tissues. These include comparisons with Xe-CT [23], Doppler ultrasound [20, 21],
LDF [12], power Doppler ultrasound [4, 22], arterial spin labeled magnetic resonance
imaging (ASL-MRI) [25, 41], fluorescent microsphere measurements [24], and to
literatures [17, 18, 26, 27, 42]. DCS systems have had their usage expanded into many
deep tissue applications including brain [5, 12, 18, 20, 21, 23-27, 29, 33-37], muscle [3,
39-41, 43, 44], and tumor [1, 2, 4, 22, 28, 30-32].
DCS can be made simple, inexpensive, and portable with short acquisition times
(from 6.5 ms up to several seconds) such that bedside monitoring is made feasible [1, 27,
29, 39]. DCS is sensitive predominantly to microvasculature instead of the larger blood
vessels. An inherent feature to using optical modalities is the noninvasive nature of
measurements without the need for imposing undesirable effects such as radiation
exposure. Spatial resolution is relatively low (~cm) governed by the volume probed
where the penetration depth is approximately half of the separation between source and
detector fibers. Thus, DCS fills a unique niche with the ability to simply and quickly
monitor blood flow in deep tissues with robust applicability.
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1.4 DCS Measurement Limitations and Current Study

Within the DCS theoretical framework, the BFI calculation has a dependence on
tissue properties, μa and μs’. Thus, calculations in the DCS flow indices will be
influenced by variations in these optical properties (see details in Chapter 2.1). An
additional potential influence on the flow indices is the laser source wavelength chosen.
As DCS requires a CW light source it is inherently incapable of monitoring absolute
tissue optical properties during flow acquisition. Two general methods commonly serve
as solutions to this dilemma: using separate instrumentation for monitoring the optical
properties or making assumptions of their values. In some recent studies, hybrid
instrumentation has been used to monitor both sets of information in order to establish
accurate blood flow data [1, 2, 21, 39, 45]. This method may be costly or unavailable and
in such cases requires making assumptions as to the optical properties of the particular
tissue being investigated. In studies where assumptions in optical properties are made
typically either the μs’ is assumed constant while μa changes are measured [24, 36, 43] or
the values for both μa and μs’ are obtained from literatures for the respective tissue type
(e.g., brain or tumor) [20, 40]. However, by making optical property assumptions there
will be an increased susceptibility to longitudinal, transient, and inter-subject deviations
from the assumed values or differences between literatures.
Another concern is that flow indices in DCS tissue measurements actually correspond
to a calculated effective Brownian diffusion coefficient (see Chapter 2.1). This diffusion
coefficient is considered to be different from the conventional Brownian diffusion
coefficient as predicted by Einstein [46]. It has been determined empirically that dynamic
scatterer motions (typically microvasculature RBC’s) are best modeled by Brownian
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diffusion rather than random ballistic flow, but the reasons for this are currently unknown
[4, 12, 18, 20, 22, 28, 29, 36]. Thus, there is a lacking in some standard of comparison for
the DCS flow index.
Currently, there has been no known generalization of potential DCS BFI errors due to
inaccuracies in the estimation of the optical properties. A formal study is needed to
elucidate upon the lack of optical property data while making DCS blood flow
measurements. We have recently built a hybrid instrument in our lab capable of
measuring flow indices using DCS and absolute μa and μs’ using NIRS at several
wavelengths simultaneously [44]. With this hybrid instrument we now have the capacity
to evaluate and quantify optical property influences on DCS flow indices at different
wavelengths. The FD NIRS system is incorporated to obtain the absolute μa and μs’ at
multiple wavelengths. These tissue optical properties are extracted from the modulated
light AC, DC, and Phase information as it passes through the sample.
We have created homogeneous liquid phantoms allowing for manipulation of the
optical property variations. NIRS and DCS techniques commonly employ liquid
phantoms to emulate tissue for experimental and calibration purposes [13, 14, 18, 47-53].
Each parameter, either μa or μs’, are varied individually to isolate their respective
influence on DCS flow indices. By using liquid phantoms a standard for comparison with
DCS is now possible. The phantoms include spherical particles suspended in liquid and
undergoing Brownian motion as modeled by Einstein. Contrary to tissue, DCS
measurements on these liquid phantoms should produce effective Brownian diffusion
coefficients (i.e., DCS flow indices) which are now equivalent to the Einstein predictions.
By utilizing this situation, the Brownian diffusion coefficient found using the Einstein-
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Stokes formula [46] can be considered a true flow index. This can subsequently be used
in comparison to DCS flow indices calculated using assumed or measured optical
properties. Errors can then be determined in DCS flow indices due to the inaccurate
optical property estimations at multiple wavelengths.
This study resolves the need for combining instrumentation to monitor both blood
flow using DCS technology simultaneously with acquisition of tissue optical properties.
We utilize liquid phantoms as a valuable means to investigate the influences of these
optical properties on DCS flow indices. In addition, through comparisons of DCS flow
indices with Brownian diffusion coefficients (true flow indices) we are capable of
quantifying measurement errors in our system and methods. To further investigate the
implications of the phantom study, a clinical study performed with the hybrid instrument
for monitoring blood flow indices and optical properties of head and neck tumors is
analyzed. Determination of in-vivo applicability involves ascertaining the measurement
errors in tumor blood flow indices which are discussed and compared to the phantom
study findings.
This thesis is organized into the following chapters. Chapter 2 opens with discussion
of the theory used in DCS BFI calculations along with a brief overview of absolute μa and
μs’ measurements and hybrid instrument operation. Details pertaining to Brownian
motion and liquid phantoms are also provided. The experimental protocols and methods
of data analysis for the phantom study and in-vivo tumor study complete the chapter. The
results of the phantom experiments and tumor study analysis are detailed in Chapter 3
with respective discussion and conclusions in Chapter 4. Finally, Chapter 5 presents the
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novel contributions in this study along with directions for future research and
investigations.
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CHAPTER 2: METHODS AND MATERIALS

A hybrid NIR diffuse optical instrument combining a commercial frequency-domain
NIR tissue-oximeter, the Imagent (ISS, Inc., IL, USA) [47, 48], and a custom-made NIR
DCS flow-oximeter [3, 37, 44] was used in this study for simultaneous measurements of
tissue optical properties and flow indices (see Fig. 2). The influences of optical properties
on blood flow indices were examined in liquid phantoms with varied optical properties
and in head and neck tumors using hybrid optical instruments. This chapter is organized
as follows. First, the theories involved in obtaining DCS flow indices (i.e., effective
Brownian diffusion coefficients) (Chapter 2.1) and tissue optical properties (i.e., μa and
μs’) (Chapter 2.2) are introduced along with the hybrid instrument data acquisition details
(Chapter 2.3). Afterwards, the manner of determining Brownian diffusion coefficients
(Chapter 2.4) is described. Next, the methods used for creating the liquid phantoms with
varied optical properties are given (Chapter 2.5). Following is a discussion of the
experimental protocols (Chapter 2.6) and data analysis (Chapter 2.7) in liquid phantoms.
Finally, particulars concerning an analysis of real tissue data in a clinical study of head
and neck tumors are provided (Chapter 2.8).
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Figure 2. Hybrid Instrument
The combined Imagent and DCS hybrid instrument used during the phantom study with: (a) hybrid optical
probe, (b) DCS flow-oximeter with 2 multi-mode laser source fibers (200 µm diameter) bundled together
(785 and 830 nm) at 1.5 cm separation from 4 single-mode detector fibers (5.6 µm diameter) bundled
together, (c) Imagent with 8 laser source fibers arranged as 1 per each wavelength at 4 separations (2.0, 2.5,
3.0, and 3.5 cm) of 780 and 830 nm along with 1 detector fiber, and (d) hybrid instrument. Note that two
additional DCS detector fibers are shown, at 2.4 and 2.8 cm separations, but were not connected for this
study.

2.1 Diffuse Correlation Spectroscopy (DCS) for Blood Flow Measurements

The dual-wavelength DCS system [44] with two long coherence length CW NIR laser
sources at 785 and 830 nm (100 mW, Crystalaser, Inc., NV, USA) is used to quantify
DCS flow indices from measurements on turbid samples such as biological tissues and
liquid phantoms. DCS laser light is emitted into the tissue alternately by means of two
multi-mode optical fibers (200 µm diameter). These fibers are bundled together on the
tissue surface at the same position (see Fig. 2). Four single-mode detector fibers (5.6 µm
diameter) are bundled and placed on the tissue surface as well with 1.5 cm separation
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from the source fiber bundle, combined into a rectangular foam pad. Each detector fiber
is connected to a single photon-counting avalanche photodiode (APD) (PerkinElmer,
Inc., Canada). A 4-channel autocorrelator board (Correlator.com, NJ, USA) receives the
outputs of the 4 APDs and produces normalized light intensity temporal autocorrelation
functions (g2). The g2’s from four detectors are averaged to improve the signal-noise-ratio
(SNR). The averaged g2 can then be related to the normalized electric field temporal
autocorrelation function (g1) through the Siegert relation [54],

r
r 2
g 2 ( r , τ ) = 1 + β g1 ( r , τ )

(1)

r

where τ is the delay time, r is the position vector, and β depends on laser stability and
coherence length and the number of speckles detected.
Although in practice DCS measures g2, the analytical solution is for g1 derived from
the transport of the unnormalized temporal electric field correlation function (G1) through
the turbid sample. The moving scatterers will contribute to the exponential decay of G1.
The transport of G1 results in the following correlation diffusion equation, derived
rigorously elsewhere [13, 14], for homogeneous media with a CW source (steady state):
r
1 ' 2
⎛
⎞ r
2
2
⎜ D∇ − vμ a − vμ s k 0 α Δr (τ ) ⎟G1 (r , τ ) = − vS( r )
3
⎝
⎠

(2)

where D = v /(3μ s' ) is the photon diffusion coefficient, v is the speed of light in the
medium, k 02 is the wavenumber, S( r ) is the source light distribution, and Δr 2 (τ ) is the
r

r

mean-square displacement of scatterers in time τ. The position vector, r , denotes a
general vector from a source to a point of detection. Notice that g1 is the normalized form
r
r
r
of G1, as used in Eq. 1, i.e., g 1 ( r , τ) = G 1 ( r , τ) / G 1 ( r ,0 ) .
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The homogeneous CW solution to Eq. 2 for semi-infinite geometry is (see Fig. 3):
G1 (ρ, τ ) =

vS0 ⎛ exp(− K (τ)r1 ) exp(− K (τ )r2 ) ⎞
⎟⎟
⎜
−
4πD ⎜⎝
r1
r2
⎠

(3)

where S0 is the source intensity, ρ is the separation distance between source and detector,

[

2
K 2 (τ) = 3μa μs' + μs'2 k 02 α Δr 2 (τ) , r1 = ρ2 + (z − z 0 )

]

1/ 2

[

, r2 = ρ 2 + (z + z 0 + 2z b )

]

2 1/ 2

, z 0 = 1 / μ s' ,

z b = 2(1 + R eff ) / 3μ s' (1 − R eff ) , R eff = −1.440 n −2 + 0.710 n −1 + 0.668 + 0.0636 n , and n ≈ 1.33

(for phantoms and tissues) [12, 13, 55, 56]. The Reff term accounts for the mismatch
between the medium and air index of refraction with n being the ratio between them.
The collimating laser source is placed at (0, 0, 0) and detector at (ρ, 0, 0) on the tissue
surface with z = 0 (see Fig. 3) for semi-infinite geometry. The solution (Eq. 3) involves
an isotropic source at z = z0 and negative isotropic imaging source at z = -(z0 + 2zb) with
r

an extrapolated zero boundary condition. The position vector, r , from Eq. 2 regards the
point source at (0, 0, z0) and negative imaging source at (0, 0, -(z0 + 2zb)). The
superposition of solutions to these two sources with infinite geometry provides the
resulting Eq. 3 where now the semi-infinite boundary is modeled by the scalar parameter,
ρ. Further details are given elsewhere [13, 56].
The movement of scatterer particles is typically characterized for biological tissues by
Brownian motion with Δr 2 (τ) = 6D B τ , where DB is the effective Brownian diffusion
coefficient. In order to differentiate static and dynamic scatterer particles, an α (0 – 1)
term is added. This term is defined as the ratio of dynamic to total scatterers from the
sample. The BFI produced by DCS in tissues is defined as the combined dynamic
scatterer ratio with the effective Brownian diffusion coefficient, i.e., αDB. The BFI can
then be used to determine the rBF by comparison with the baseline BFI, BFIBaseline, prior
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to any physiological changes, i.e., rBF = BFI / BFI Baseline . In tissue samples, scatterers
may be static (e.g., mitochondria, organelle) or dynamic (RBC). However, in liquid
phantom solutions (see Chapter 2.5) all scatterers are dynamic resulting in α ≈ 1. Thus,
the DCS flow indices in this thesis related to the phantom study are reported as just DB.

g1 measured
Siegert
Relationship
g2 measured
Autocorrelator
DCS
Lasers

Photodetector
ρ

y
x
z

Fit analytical g1
by varying αDB
αDB (flow)

Figure 3. DCS Data Acquisition
The process of DCS data acquisition beginning with tissue measurement (bottom left) and ending with
(bottom right) production of a DCS flow index (αDB). Cartesian coordinates are shown with respect to DCS
source-detector and tissue orientation with the y-axis directed into the page. A typical correlation curve is
shown as an example, taken from a phantom experiment (μa (830 nm) = 0.05 cm-1, μs’ (830 nm) = 10 cm-1)
with g1 derived from g2 measurements (g1m) using Eq. 1 and g1 calculated (g1c) using Eq. 3.

r
To quantify a flow index, g 2 ( r , τ) is first obtained for a given sampling time (~44
ms) from the correlator where the sample is illuminated by a DCS source (either 785 or
14

830 nm). Multiple samples are obtained and averaged during a measuring time of ~1.2 s.
From Eq. 1, β is found at τ ≈ 0 using measured g 2 (ρ,0) and g1 (ρ,0) ≈ 1 (i.e.,
g 1 (ρ,0 ) = G 1 (ρ,0) / G 1 (ρ,0) = 1 ).

This leads to β = g 2 (ρ,0) − 1 . It is assumed that β will remain

constant throughout the remaining τ since it only depends on the optical system [15].
Now, g 1 (ρ, τ) can be calculated for all τ with Eq. 1 using measured g 2 (ρ, τ) and calculated
β. The flow index (αDB) is then considered an unknown parameter in Eq. 3, which is fit
with the g 1 (ρ, τ) calculated previously. For each DCS data acquisition sequence, a unique
flow index is obtained for 785 and 830 nm. Two flow indices are obtained sequentially to
obtain a complete frame of DCS data acquisitions at two wavelengths. The overall
process of DCS data acquisition is given in Fig. 3.

2.2 Frequency Domain Spatially Resolved Near-Infrared Spectroscopy for
Measurement of Optical Properties

A four-wavelength (690, 750, 780, and 830 nm) FD multi-distance spatially resolved
spectroscopy instrument, i.e., the Imagent, is incorporated to quantify absolute μa and μs’.
Only two wavelengths (780 and 830 nm) were chosen so as to match the available DCS
lasers (785 and 830 nm). Imagent measurements are obtained similar to DCS with semiinfinite geometry, by emitting NIR light into the tissue through source fibers with
detector fibers up to a few cm away, both at the tissue surface. The FD Imagent system
emits light sinusoidally modulated at 110 MHz. Optical fiber arrangement consists of 8
source fibers (4 per wavelength) placed at four pre-determined distances (2.0, 2.5, 3.0,
and 3.5 cm) from a detector fiber bundle. The detector fiber is connected to a
photomultiplier tube (PMT) (see Fig. 2). Utilizing the amplitudes of light signal
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modulation (ac), average (dc), and phase (φ), information can be detected from the
different source-detector separations (r). It was found that linear relationships exist
between logarithmic ac, logarithmic dc or φ and the spatial distances through solutions to
a photon diffusion equation [48]. The slopes (Slac, Sldc, Slφ) of these linear relationships
can be fit from the multi-distance measurements. From these slopes μa and μs’ can be
determined at both wavelengths. For the phantom study, by use of homogeneous
phantoms the different source and detector separations are expected to have minimal
effect on the measured optical properties despite probing different depths. In the real
tissue tumor study analysis this effect may be more prominent (see Chapter 3.4).
In Imagent operation, the fitting solutions mentioned above are not ideal for real
tissue measurements due to the requirement of iterative calculations. Therefore, a faster
approximate solution is employed defined by the following equations [57]:

(

)

(

)

(4)

)

(5)

ln dc r 2 = rSl dc μ a , μ s' + In 'dc (D, K dc )

(

Φ = rSl Φ μ a , μ s' , ω, v + In Φ' (K Φ )

(

)

(

)

ln ac r 2 = rSl ac μ a , μ s' , ω, v + In 'ac (D, K ac )

(6)

where ω is the angular frequency of the modulation, v is the speed of light in the medium,
D is the photon diffusion constant ( D ≈ 1 / 3μ s' ), KΦ is the relative phase of the source plus
any phase shifts outside the sample, Kac and Kdc are constants dependent on detector
sensitivity factors, modulation depth, and source intensity, and In’dc, In’Φ, and In’ac are
the line intercepts. Only two of the three slopes are required per wavelength to obtain
corresponding μa and μs’, but using the combination of Slac and SlΦ eliminate influences
form background light [47].
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2.3 Hybrid Instrument Data Acquisition

The hybrid instrument alternates data acquisition sequentially between DCS and
Imagent. An individual acquisition sequence begins with DCS activating the first laser
and collecting data from the autocorrelator. The first laser is then switched off and the
process is repeated for the second DCS laser. Notification is then sent from DCS to the
Imagent via a TTL trigger to proceed with an iteration of data acquisition. The Imagent
activates an individual laser source at the first distance collecting data from the PMT.
Data is collected similarly for the Imagent laser activated alternately at each distance. The
Imagent laser is then shut off and each remaining Imagent laser source (at different
wavelengths) is sequentially activated to acquire data in the same manner before finally
returning control to the DCS. The notification to DCS signifies the completion of one
data acquisition cycle, which is then repeated until the end of the measurement. Total
data acquisition time per frame is ~2.7 s (~1.2 s for each of two DCS wavelengths and
~0.3 s for Imagent). After the measurement is finished Imagent places AC, DC, and
Phase information into a .txt file. The .txt file is further analyzed by supplemental
Imagent processing functions, such as to produce μa and μs’, and saved in a .log file.
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2.4 Particle Brownian Motion in Liquid Phantoms

For comparisons with DCS flow indices, Einstein Brownian diffusion coefficients are
determined for liquid phantoms. Intralipid particles provide Brownian motion within the
phantoms. This motion is expected to be equivalent to the effective Brownian diffusion
coefficient (flow index) as measured using DCS [46]. Determination of the phantom
diffusion coefficient follows calculations per the Einstein-Stokes formula for spherical
particles suspended in liquid defined as:

DB =

k BT
6πRη

(7)

where R is the Intralipid spherical particle radius, η is the viscosity of the phantom, T is
the temperature of the phantom, and kB is the Boltzmann constant [46]. Due to difficulties
in measuring the Intralipid particle radius, an estimation of 196 nm is used (see Chapter
2.7). The phantom viscosity is measured with a commercial viscometer (Brookfield, MA,
USA). The viscosity parameter is reported in units of cP (centipoise), where 1 cP = 1
mPa·s (millipascal·second) = 0.001 kg·m-1s-1 [58]. Measurement of the phantom
temperature is obtained via a temperature sensor (Physitemp, NJ, USA) attached near the
hybrid probe. For further details on acquisition of this data see Chapter 2.6.

2.5 Liquid Phantom Creation

We follow previously published methods for creating liquid phantoms, but examine
implementation details thereof here for clarity and re-creation purposes. The composition
of liquid phantoms consist of India ink (Black India 44201, Higgins, MA, USA),
Intralipid (30%, Fresenius Kabi, Uppsala, Sweden), and distilled water. Originally
deionized water was used, but was difficult to obtain and produced similar results to
18

distilled water for our purposes. The complete liquid phantom setup can be seen in Fig. 4.
The phantom solution is contained within a 9607.5 cm3 aquarium (~9.5 L). The hybrid
fiber-optic probe (see Fig. 2) is positioned on the phantom surface simulating superficial
tissue measurement configuration of semi-infinite geometry. To keep the probe
stationary, a custom probe holder was built by a machine shop. The holder maintains the
probe near the center of the phantom solution, away from aquarium boundaries.

x
y

z

Figure 4. Liquid Phantom Setup
Hybrid instrument (left) and liquid phantom (right) setup including: ~9.5 L glass aquarium (30.5 cm x 21.0
cm x 15.0 cm), hybrid optical probe with holder, lab stand and Cartesian coordinates oriented for DCS
source and detector.

A 30% Intralipid solution provides particle Brownian motion, as described by Eq. 7.
Additionally, it is used to manipulate the phantom reduced scattering coefficient, μs’
phantom,

while contributing minimally to phantom absorption. The phantom absorption
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coefficient, μa

phantom,

is manipulated using the India ink with minimal influence on

phantom scattering. Due to the very high contribution of absorption from pure India ink,
a solution of 10% ink with 90% distilled water is created. The 10% solution is used rather
than pure ink to manipulate the μa

phantom.

Distilled water contributes little to both

phantom absorption and scattering, allowing for larger phantom volumes to facilitate
satisfying the semi-infinite geometry model. The subscripts “water”, “ink”, and
“Intralipid” denote distilled water, 10% ink solution, and 30% Intralipid, respectively.
Prior to prediction of phantom optical properties, the μa and μs’ of the contributing
solutions must first be determined. These values will then be used in combination with
titration equations for predicting the volumes of water, 10% ink solution, and 30%
Intralipid needed to obtain the phantom optical properties required.
Intralipid, ink, and water μa. Spectrometer (Beckman Coulter, CA, USA)

measurements allow derivation of the 10% ink solution absorption coefficient, μa ink. The
10% ink solution is not within the measurable range of the spectrometer. Thus, for
absorbance measurements the 10% solution is further diluted to a 0.025% ink solution (of
ink and water). Multiple samples of the 0.025% ink solution are distributed into
individual 1 cm path-length cuvettes and scanned by the spectrometer at 780 and 830 nm
(matching the Imagent source wavelengths). These absorbances are averaged and
converted to absorption by: μa ink (λ) = ln (10) x Absorbance (λ) [59]. Values for μa water at
780 and 830 nm are obtained from the literature [60]. As Intralipid is primarily comprised
of water, it is assumed to have an absorption coefficient equivalent to water, i.e. μa Intralipid
= μa water.
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Intralipid, ink, and water μs’. The μs’ of 30% Intralipid is derived from the

theoretical values for 10% Intralipid. The μs’ of 10% Intralipid is first calculated using a
Mie theory approximation and subsequently multiplied by a factor of three to obtain the
μs’ of 30% Intralipid, μs’

Intralipid

[59]. The Intralipid particle radius and refractive index

along with related theory and details are described in the original derivation [61], which
has been used extensively for quantification of Intralipid-based liquid phantoms [12, 14,
59, 62, 63]. As there are expected to be no contributions to the phantom scattering by the
10% ink solution or distilled water both are ignored in calculations, i.e., μs’ ink = μs’ water =
0 cm-1.
Liquid phantom μa variation. A list of desired μa and a constant μs’ must first be

chosen at a specific wavelength for creating phantoms with varied μa (see Chapter 2.6).
Optical properties at other wavelengths are found later, once the phantom composition
has been predicted. The available aquarium size is considered the total phantom volume,
Vphantom. Volumes of distilled water (Vwater), 10% ink solution (Vink), and 30% Intralipid
(VIntralipid) required to obtain the set of μa and μs’ are then calculated for the initial
phantom. For our experiments, the initial phantom optical properties at 830 nm are: μa
phantom

(830 nm) = 0.05 cm-1 and μs’phantom (830 nm) = 10 cm-1. Using a titration equation,

the 10% ink solution volume (Vink) can be determined as follows [59]:
μa

water

(830nm )

x (Vphantom − Vink ) + μ a

ink

(830nm )

x Vink = μ a

phantom

(830nm )

x Vphantom
(8)

The volume of 30% Intralipid (VIntralipid) is determined using a similar titration
equation [59],
μ s' Intralipid (830nm ) x VIntralipid = μ s' phantom (830nm ) x Vphantom
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(9)

The volume of distilled water is simply the remaining volume to be filled, calculated
by: Vwater = Vphantom – Vink – VIntralipid. The 10% ink solution will be added in equivalent
amounts each step to increase the phantom μa. Generalizing the titration equation to the
add
, is given by [59]:
volume of 10% ink solution to add, Vink
i −1
μ ia−1 phantom (830nm ) x Vphantom
+ μa

ink

(830nm )

add
x Vink
= μ ia

phantom

(830nm )

i −1
add
x (Vphantom
+ Vink
)

(10)
where i is the step (i.e., i = current step, i-1 = previous step). Notice that the total
phantom volume for the next step will be the sum of the 10% ink solution volume added
with the current volume. After the volumes have been determined Eq. 8 and Eq. 9 can be
used with known volumes and constituent optical properties to predict the μa

phantom

(λ)

and μs’ phantom (λ) at other desired wavelengths.
Liquid phantom μs’ variation. The process for varying the phantom μs’ is like that

of μa variation, starting with selection of the constant μa and list of μs’ (see Chapter 2.6).
The initial phantom is created from the volumes of distilled water, 10% ink solution, and
30% Intralipid as calculated using Eq. 8 and 9. The desired initial phantom optical
properties are: μa phantom (830 nm) = 0.125 cm-1 and μs’phantom (830 nm) = 4 cm-1. Contrary
to the μa variation, both 30% Intralipid and 10% ink solution need to be added at each
step for μs’ variation. The additional 30% Intralipid each step contributes additional
volume and lowers the phantom absorption. To account for these factors requires
matching the μa of the added 30% Intralipid to that of the phantom. This will maintain a
add

constant phantom μa. The volume of 30% Intralipid to be added ( VIntralipid ) is determined
by the following titration equation [59]:
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μ s' phantom (830nm ) x Vphantom + μ s'
i −1

Intralipid

(830nm )

(

add
x VIntralipid

add
= μ s' phantom (830nm ) x Vphantom + VIntralipid
i

)

(11)

add
The quantity of 10% ink solution to be added ( Vink
) is determined by a slightly

modified form of Eq. 10 [59],
μ ia−1 phantom (830nm ) x Vphantom + μ a

= μ ia

phantom

ink

(830nm )

(830nm )

add
x Vink
+ μa

water

(830nm )

add
x VIntralipid

add
add
x (Vphantom + Vink
+ VIntralipid
)

(12)

Once the additional volumes of 10% ink solution and 30% Intralipid are added and
mixed

with

the

phantom

solution,

an

equivalent

volume

to

that

added

add
add
+ Vink
) is removed to maintain probe submersion depth. These
( Vremove = VIntralipid

procedures are repeated for all remaining steps. To predict the optical properties at other
wavelengths, the percentage of each constituent must first be determined. It is assumed
the percentages are equivalent in the amount of volume removed as to the entire
phantom. This allows one to obtain their corresponding volumes at every step. Then Eq.
8 and 9 are used as is done with μa variation to predict the μa phantom (λ) and μs’ phantom (λ)
at desired wavelengths.

2.6 Phantom Experimental Protocols
μa variation. In the first experiment, the μs’ was maintained constant throughout: μs’

(830 nm) = 10 cm-1. Conversely, μa was varied in an increasing manner consisting of
thirteen steps. The absorption range covers µa (830 nm) from 0.05 to 0.20 cm-1 with a
step size of 0.0125 cm-1 (i.e., µa (830 nm) = 0.05, 0.0625, 0.075, …, 0.20 cm-1).
Calibration of the Imagent with a phantom of known optical properties is done prior to
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starting measurements. During calibration, corrections are made accounting for the
efficiency of optical coupling among the lasers/detector, optical fibers, and phantom [47,
57]. A liquid phantom of equivalent composition and optical properties as the midpoint
(step 7) was used for calibration. The initial phantom was created consisting of optical
properties at the lowest step, i.e., µa (830 nm) = 0.05 cm-1. The hybrid probe with
temperature sensor was placed onto this phantom and the following actions were taken
for each of the 13 steps. The volume of 10% ink solution to add was determined as
detailed in Chapter 2.5. This volume was then added to the liquid phantom via a pipette,
mixed, and left to settle for 10 minutes while the optical properties and flow stabilized.
During the 10 minute period three 500 μL samples were extracted from the phantom for
viscosity measurements. The samples were taken from the right, middle, and left of the
solution to minimize spatial variations. The pipette sampled from within 1-2 cm of the
surface to prevent submersion. All lights in the room were switched off or covered with
black tape. Black plastic was used to cover the phantom setup to reduce any remaining
ambient light. Hybrid optical measurements (including temperature) were obtained for an
interval of 5 minutes duration.
μs’ variation. The second experiment maintained a constant μa throughout: µa (830

nm) = 0.125 cm-1. The μs’ was increased over a total of thirteen steps. The scattering
range covers µs’ (830 nm) from 4 to 16 cm-1 with a step size of 1 cm-1 (i.e., µs’ (830 nm)
= 4, 5, 6, …, 16 cm-1). This experiment immediately followed the μa variation. Prior to
instantiating this second phase, the μa variation phantom was disposed of and replaced by
the μs’ variation initial phantom. Alcohol pads were used to clean the probe before
repositioning it onto the initial phantom. The DCS and Imagent were not shut down
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between protocols. Two potential difficulties arise with the addition of 30% Intralipid due
to the amount required: potential reduction in the phantom μa and probe submersion. The
addition of 10% ink solution with that of the additional 30% Intralipid allows the μa of
the phantom to be maintained. To prevent probe submersion, after mixing at each step an
equivalent amount of phantom solution is removed. Hybrid optical, temperature, and
viscosity measurements were obtained in the same manner as during μa variation.

2.7 Phantom Data Analysis

For each 5 minute interval, the following parameters were obtained through
measurements and post-analysis calculations: μa, μs’, temperature, viscosity, and three
diffusion coefficients (DB’s). Note that in all cases except viscosity, data between
intervals (i.e., making additions, stirring) is not included in data analysis. Interval
averages were found for μa and μs’ at both wavelengths (780 and 830 nm) over each 5
minute interval. Temperature is also averaged over each 5 minute interval. Viscosity
measurements were obtained at 50, 60, and 100 RPM for each of three samples and
averaged. The liquid phantom was assumed a Newtonian fluid. The three sample average
was then calculated to produce the mean viscosity per interval. Using the averaged μa and
μs’ as known parameters DCS measured g1’s, calculated from Eq. 1 with measured g2, are
fit using Eq. 3 to produce two distinct DB’s. Subscripts denote which set of optical
properties (assumed or measured) were used in order to differentiate the two DB’s. For
assumed optical properties, the averaged µa and µs’ from the middle interval (step 7), i.e.,
µa (830 nm) = 0.125 cm-1 and µs’ (830 nm) = 10 cm-1, are used in calculations of the first
DCS DB, termed DB-mid. The DB-mid represents the diffusion coefficient without

25

consideration as to any optical property variations. Errors are induced in flow index
calculations by forcing the varying optical property to be held constant. During early
intervals the middle interval overestimates µa (first experiment) and µs’ (second
experiment) while at later intervals it underestimates. Corresponding interval µa and µs’
averages are used in calculation of the second DCS DB, termed DB-dynamic. This DB is
considered the best evaluation of DCS flow index. DB-mid and DB-dynamic are calculated at
both DCS wavelengths used, 785 and 830 nm. The DCS DB calculations at 785 and 830
nm utilized the averaged optical property data from the Imagent at 780 and 830 nm,
respectively. The influence from wavelength mismatch between 780 and 785 nm is
considered to be minor. The two sets of DCS DB’s, at each wavelength, are calculated
then averaged over the 5 minute interval. A third DB is calculated by Eq. 7, termed DBEinstein,

with the three sample averaged viscosity, interval averaged temperature, and

estimated particle radius. The Intralipid particle radius estimation was found to exhibit
the least errors between the measured DCS flow indices (DB-dynamic) and calculated DBEinstein

at the calibration point (step 7). This estimation, 196 nm, is within the Intralipid

particle size range as reported in the literatures [14, 61].
Figures and tables are used for results presentation to visualize measurement
variations, optical property influences on DCS flow indices, and differences between
predicted and measured values. Error bars illustrate standard deviations (SD) and data are
depicted as mean ± SD. Percentage errors between measured and predicted values were
calculated and used to characterize measurement errors. Student t-test p-values are
presented to compare measurement errors, while the significance criterion is p < 0.05.
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2.8 Head and Neck Tumor Study Protocol and Data Analysis

The phantom study results provide a general view of errors in flow indices due to
constant optical properties assumptions. In order to more easily visualize the implications
of such assumptions on real tissue measurements, in-vivo data from an ongoing tumor
study is analyzed. A hybrid optical instrument, similar to that in the phantom study, was
employed in measuring tissue hemodynamic properties of head and neck tumors in 10
patients. Inclusion was restricted to only those patients with Stage III-IVb Squamous Cell
Carcinoma of the Head and Neck (SCCHN). Further selection criteria included neck
lymph nodes that measured greater than 1 cm and were clinically thought to be involved
by tumor. Subjects completed consent forms and institutional review board (IRB)
approval was given by the University of Kentucky prior to participation in the study.
Not all DCS and Imagent laser sources used in the phantom study were available for
the tumor study and, as a result, some differences are encountered. DCS employed lasers
at 785 and 854 nm whereas the Imagent had 690 and 830 nm. The best match between
source wavelengths of the two instruments, for data analysis, was determined to be 854
nm for DCS and 830 nm for Imagent. Due to the large gap between the other two
sources, 785 versus 690 nm, they are excluded from this analysis. The Imagent source
and detector fiber separations are identical as that in the phantom study (i.e., 2.0, 2.5, 3.0,
and 3.5 cm). Three source and detector separations were achieved with DCS, utilizing 3
detector fibers at 1.5, 2.4, and 2.8 cm from the bundled source fibers. For the phantom
study, homogeneity was assumed for all source and detector separations. However, in the
tumor study our analysis focuses on the 2.8 cm separation from DCS as it is expected to
be most comparable to the tissue region/depth probed by the Imagent. The handheld
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probe was placed on the tissue surface at the center of the area identified as tumor node,
as applicable to the semi-infinite geometry model, and secured in position. DCS flow
indices and optical property data were acquired for a duration of ~2 minutes.
Optical properties were obtained by Imagent, as done in the phantom study, and
averaged over the 2 minute measurement interval for the 10 patients. Calculations with
four different sets of measured optical properties produced four unique DCS flow indices.
The true DCS flow index is considered that which is calculated with the true
corresponding patient μa and μs’ (i.e., averaged Imagent data over 2 minutes), and is
termed αDB-dynamic. The remaining three DCS flow indices are calculated using the overall
patient minimum, mean, and maximum optical properties, termed αDB-min, αDB-mean, and
αDB-max, respectively. These DB estimates are compared with the true flow index, αDBdynamic,

for determining errors. Error bars in figures correspond to SD, and data are

presented by interval mean ± SD.
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CHAPTER 3: RESULTS

Presentation of results is ordered as follows. First, data related to the calculations of
Brownian diffusion coefficients (DB-Einstein) and DCS flow indices are given for μa
variation in liquid phantoms (Chapter 3.1). In a similar fashion, these findings from μs’
variation are then reported (Chapter 3.2). The next section (Chapter 3.3) summarizes the
influence of μa and μs’ variations on flow indices and is divided into three subsections:
the influence of μa and μs’ variations on DB-Einstein, the measurement errors found for μa,
μs’ and DCS flow indices compared to predicted values, and the influence of inaccurate
estimations of μa and μs’ on DCS flow indices. Finally, the influence of tissue optical
properties on DCS blood flow indices of head and neck tumors is presented (Chapter
3.4).

3.1 μa Variation

The first experiment performed consists of varying the μa of a liquid phantom while
maintaining a constant μs’ to evaluate the influences on DCS flow indices. Thirteen steps,
with a μa step size of 0.0125 cm-1, were carried out over µa (830 nm) from 0.05 to 0.20
cm-1 with μs’ (830 nm) = 10 cm-1. At 780 nm, the μa will also increase and have constant
μs’, but manipulations were purposely invoked at 830 nm only. Measurements were
obtained for thirteen separate 5 minute intervals. These were analyzed post measurement
producing data sets of mean and SD’s per interval for viscosity, temperature and three
DB’s. The viscosity, temperature and true flow index, calculated DB-Einstein, are shown in
Fig. 5 – 7, respectively, with error bars designating the SD’s. Each DB-Einstein (Fig. 7) is
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calculated with the measured interval temperature (Fig. 6), corresponding viscosity (Fig.
5), and estimated particle radius (196 nm).

Raw data and interval means with SD’s (as error bars) of measured and true μa, μs’,
DB-Einstein, DB-mid, and DB-dynamic during μa variation at the employed wavelengths are
displayed in Fig. 8 – 14. For raw data figures (Fig. 8, 10, 12, and 13), the black vertical
lines indicate separation between 5 minute data acquisition intervals and frame numbers
serve as a generic counter as the data between intervals has been excluded for clarity. To
quantify measurement errors for the optical properties, predictions using Mie theory
estimations and spectrometer results are used as true values for comparisons to μs’ and μa,
respectively. Calculated DB-Einstein is not wavelength dependent and thus is the same for
comparisons with DCS flow indices, DB-dynamic and DB-mid, at both wavelengths. Averaged
optical properties at the middle interval [µa (830 nm) = 0.125 cm-1 and µs’ (830 nm) = 10
cm-1] are used for calculations of DB-mid and from corresponding intervals for DB-dynamic.

Figure 5. Viscosity During μa Variation
Viscosity as averaged from three samples corresponding to each step, depicted as means ± SD’s (as error
bars), during μa variation. Small variations can be seen within steps attributable to variations in sample
measurements. Viscosity during step 2 has larger variations than other steps for reasons unknown, but is
possibly due to operational error. The variation in viscosity across all steps is relatively low indicating
stability of this parameter.
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Figure 6. Temperature During μa Variation
Temperature as averaged over 5-minute intervals, depicted as means ± SD’s (as error bars), during μa
variation. Temperature variations within each step are small. An increasing trend is apparent and most
likely the result of increasing ambient temperature within the confined room during measurements. The
overall variation is small and the parameter is considered stable.

Figure 7. Brownian Motion During μa Variation
Stability of particle Brownian motion, with DB-Einstein for corresponding 5-minute intervals, during μa
variation. The stability of this variable is exhibited with only minor variations. These fluctuations are due to
the small viscosity and temperature variations governed by Eq. 7.
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Figure 8. Raw Data of Imagent Measured μa at 780 and 830 nm During μa Variation
Imagent measured μa at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μa variation. The noise is relatively low at early intervals, but increases significantly near higher μa
with decreases in Imagent detected intensity.

Figure 9. μa at 780 and 830 nm During μa Variation
Imagent measured μa, shown as interval means ± SD’s, and μa predicted using spectrometer measurements
at 780 nm (left) and 830 nm (right) for μa variation. Increases in Imagent measured μa are in agreement with
spectrometer predictions. The agreement is better at 830 nm which may be due to the detection accuracy of
Imagent at separate wavelengths. Measurement variations within intervals can be seen to increase with the
increasing noise shown in Fig. 8.
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Figure 10. Raw Data of Imagent Measured μs' at 780 and 830 nm During μa Variation
Imagent measured μs’ at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μa variation. The noise is low at early intervals and continually increases with the addition of ink at
each step as Imagent detected intensity decreases. The μs’ at both wavelengths are relatively stable
throughout the measurement.

Figure 11. μs' at 780 and 830 nm During μa Variation
Imagent measured μs’, shown as interval means ± SD’s, and μs’ predicted from Mie theory approximations
at 780 nm (left) and 830 nm (right) for μa variation. Small deviations between Imagent measured μs’ and
Mie theory predictions can be seen, but are within expectations (see Chapters 3.3 and 4.2). Measurement
variations within intervals can be seen to increase with the increasing noise shown in Fig. 10.
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Figure 12. Raw Data of DCS Measured DB-dynamic at 785 and 830 nm During μa Variation
DCS measured DB-dynamic at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle
(frame) during μa variation. Noise levels after averaging from four detectors is low for all intervals. A
slightly increasing trend may be due to the decreases in diffusion applicability from increasing μa compared
to μs’.

Figure 13. Raw Data of DCS Measured DB-mid at 785 and 830 nm During μa Variation
DCS measured DB-mid at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μa variation. Noise levels after averaging from four detectors is low for all intervals, the same as for
DB-dynamic (see Fig. 12). The largely decreasing trend is expected to be due to the lack of accounting for
changes in the optical properties.
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Figure 14. DB at 785 and 830 nm During μa Variation
DCS DB-dynamic and DB-mid, shown as interval means ± SD’s, and Brownian diffusion coefficients, DB-Einstein,
at 785 nm (left) and 830 nm (right) for μa variation. This figure overlays the DB-Einstein from Fig. 7 with the
interval means of DCS measured DB-mid and DB-dynamic from Fig. 12 and 13. Deviations between DB-mid
appear to be much greater than DB-dynamic in comparison to DB-Einstein (true flow index) indicating DB-dynamic as
the more accurate flow index.

3.2 μs’ Variation

Results of the μs’ variation experiment are given in the same format as that for μa
variation. Thirteen steps of increasing μs’ were carried out with a step size of 1 cm-1
covering µs’ (830 nm) from 4 to 16 cm-1 with constant µa (830 nm) = 0.125 cm-1. The
viscosity, temperature, and calculated DB-Einstein means with SD’s as error bars are
displayed in Fig. 15 – 17, respectively. Note that the same DB-Einstein set is used as the true
flow indices for comparison with both DCS source wavelengths. Raw data and interval
means of measured μa, μs’, DB-Einstein, DB-dynamic, and DB-mid with SD error bars are shown
in Fig. 18 – 24 along with predicted μa and μs’ (as done in Chapter 3.1). Raw data figures
(Fig. 18, 20, 22, and 23) are presented in a similar fashion to Chapter 3.1.
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Figure 15. Viscosity During μs' Variation
Viscosity as averaged from three samples corresponding to each step, depicted as means ± SD’s (as error
bars), during μs’ variation. These measurements exhibit small variations within steps due to sample
variations, but are stable overall. Step 2 has larger variations for reasons possibly due to operational error.

Figure 16. Temperature During μs' Variation
Temperature is averaged over 5-minute intervals, depicted as means ± SD’s (as error bars), during μs’
variation. Temperature variations within each step are small, but overall stable with a generally increasing
trend caused from increases in ambient temperature within the confined room throughout measurements.
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Figure 17. Brownian Motion During μs' Variation
Stability of particle Brownian motion, with DB-Einstein for corresponding 5-minute intervals, during μs’
variation. This variable shows as stable with only minor variations caused by small viscosity and
temperature variations governed by Eq. 7.

Figure 18. Raw Data of Imagent Measured μa at 780 and 830 nm During μs' Variation
Imagent measured μa at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μs’ variation. The noise is slightly higher than during μa variation at early intervals, likely due to the
high Intralipid concentration, increasingly worsening throughout the measurement. The μa is relatively
stable overall with a small jump occurring from the first and second intervals at 780 nm. This jump may be
caused by near saturation of the Imagent detectors at the earliest interval.
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Figure 19. μa at 780 and 830 nm During μs' Variation
Imagent measured μa, shown as interval means ± SD’s, and μa predicted using spectrometer measurements
at 780 nm (left) and 830 nm (right) for μs’ variation. The deviations between Imagent measured μs’ and Mie
theory predictions are minor, but within expectations (see Chapters 3.3 and 4.2). Measurement variations
within intervals can be seen to increase with the increasing noise shown in Fig. 18.

Figure 20. Raw Data of Imagent Measured μs' at 780 and 830 nm During μs' Variation
Imagent measured μs’ at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μs’ variation. Noise is low early and increases with each step and the addition of Intralipid which
decreases the Imagent detected intensity.
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Figure 21. μs' at 780 and 830 nm During μs' Variation
Imagent measured μs’, shown as interval means ± SD’s, and μs’ predicted from Mie theory approximations
at 780 nm (left) and 830 nm (right) for μs’ variation. Increases in Imagent measured μs’ are in agreement
with Mie theory predictions. The agreement at 780 nm appears better which may be due to the detection
accuracy of Imagent at separate wavelengths, similar to μa during μa variation (see Fig. 9). Measurement
variations within intervals can be seen to increase with the increasing noise shown in Fig. 20.

Figure 22. Raw Data of DCS Measured DB-dynamic at 785 and 830 nm During μs' Variation
DCS measured DB-dynamic at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle
(frame) during μs’ variation. Noise levels are low for all intervals with detector averaging. The trend is
decreasing at early intervals before stabilizing around the fourth and fifth intervals. This is possibly due to
poor diffusion from a low μs’ compared to μa.

39

Figure 23. Raw Data of DCS Measured DB-mid at 785 and 830 nm During μs' Variation
DCS measured DB-mid at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame)
during μs’ variation. Noise levels are low as was the case for DB-dynamic (see Fig. 22). There is a largely
increasing trend due to the lack of accounting for changes in the optical properties.

Figure 24. DB at 785 and 830 nm During μs' Variation
DCS DB-dynamic and DB-mid, shown as intervals means ± SD’s, and Brownian diffusion coefficients, DB-Einstein,
at 785 nm (left) and 830 nm (right) for μs’ variation. As was done for μa variation, this figure overlays the
DB-Einstein from Fig. 17 with the interval means of DCS measured DB-mid and DB-dynamic from Fig. 22 and 23.
Deviations between DB-mid are significantly greater than DB-dynamic in comparison to DB-Einstein (true flow
index) indicating DB-dynamic as the more accurate flow index.
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3.3 Quantification of μa and μs’ Influences on Flow Indices
Influence of μa and μs’ variations on DB-Einstein. Variations in phantom optical

properties are examined to determine any potential influences on DB-Einstein. Using the
data displayed in Fig. 5 – 7 and 15 - 17, the means, SD’s, and coefficients of variation
(CV) were calculated over the entire μa and μs’ variation experiments for viscosity,
temperature, and DB-Einstein. The results are shown in Table 1, with experiments separated
into different columns. No major influences are noticeable on DB-Einstein or related
parameters with CV’s less than 2.2% for all three in both optical property variations.
With this knowledge, the DB-Einstein is considered viable as the true flow index for
determining measurement errors in DCS flow indices.

Table 1. Mean ± Standard Deviation and Coefficients of Variation of Viscosity, Temperature, and
Brownian Motion

Variables

μa variation

μs’ variation

Mean ± SD

CV

Mean ± SD

CV

Viscosity (cP)

0.98 ± 0.02

1.54%

0.96 ± 0.02

2.12%

Temperature (°C)

18.61 ± 0.20

1.05%

18.80 ± 0.12

0.64%

DB-Einstein (cm2/s)

1.05E-08 ± 1.65E-10

1.57%

1.07E-08 ± 2.25E-10

2.11%

Mean measurement errors in μa, μs’ and DCS flow indices. Measurements errors

are described using absolute percentage errors defined as:
Absolute Percentage Error =

Estimate − True
True
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x100%

(13)

In the case of DCS flow indices, DB-Einstein is considered the true flow index whereas DBdynamic

and DB-mid are estimates. Estimated μa and μs’ are those averaged from

measurements while true values are from spectrometer and Mie theory predictions,
respectively. Using the estimated and true data (shown in Fig. 9, 11, 14, 19, 21, and 24)
over the complete range of μa and μs’ variations, measurement errors were calculated and
their means ± SD’s are shown in Table 2. P-values are also shown for 2-sample unequal
variance, two-tailed Student t-tests between mean measurement errors at the wavelengths
used. Significant differences are denoted with a * prefix when p-values are less than 0.05.
Measurement errors for μa and μs’ are less than 6% for both experiments and sets of
wavelengths. DCS flow indices, however, exhibit some discrepancies amongst their
measurement errors. Errors in DB-mid are overall higher than those of DB-dynamic, indicating
optical properties influence in DCS DB calculations. Variations in μs’ appear to contribute
a greater influence on flow index errors than μa variations, as identified by DB-mid errors
up to 12.89% during μa variation and 49.63% during μs’ variation. Student t-test results
identified significant differences between mean measurement errors at 780 and 830 nm
for μa during μa variation (p = 0.01) and μs’ during μs’ variation (p = 0.04). Detection
accuracy of the Imagent at the different wavelengths is thought to be the greatest
attributor to these differences. No other significant differences were found between the
mean measurement errors at both wavelengths.
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Table 2. Imagent/DCS Measurement Percentage Errors at 780/785 nm (shaded) and 830/830 nm
(non-shaded)

μa variation (Absolute % Error)
Variables

Mean ± SD

p-value

μs’ variation (Absolute % Error)
Mean ± SD

780 nm

3.39 ± 3.07

830 nm

0.84 ± 0.95

1.86 ± 1.15
2.86 ± 2.69

780 nm

1.93 ± 1.23

3.14 ± 2.66

830 nm

1.60 ± 1.50

785 nm

5.52 ± 3.69

*0.01

μa

μs’

0.23

0.54

DB-dynamic

*0.04
5.29 ± 2.27
5.84 ± 10.73

0.28
830 nm

4.02 ± 3.30

785 nm

12.89 ± 12.00

DB-mid

0.83
6.58 ± 6.16
49.63 ± 31.51

0.64
830 nm

p-value

10.89 ± 8.99

0.81
46.76 ± 27.44

* p-values < 0.05

For both experiments, Student t-tests were also used for comparisons between the
mean measurement errors of DB-mid and DB-dynamic, within the same wavelengths, as shown
in Table 3. Significant differences are determined and noted similarly as done in Table 2.
It is readily seen that DB-mid and DB-dynamic are not equivalent by the significant (although
for 785 nm during μa variation it is borderline) differences found for both wavelengths
and experiments. Additionally, DB-dynamic is considered more accurate as it provides less
measurement errors (see Table 2). As similarly suggested from Table 2, the μs’ influence
on DCS flow indices is greater than μa as indicated by much lower p-values during μs’
variation.
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Table 3. P-values for Comparisons of the Mean Measurement Errors Between DCS Flow Indices
Calculated with Dynamic Vs. Assumed Constant Optical Properties

DB-dynamic vs. DB-mid

μa variation (p-value)

μs’ variation (p-value)

785 nm

0.0525

*0.0003

830 nm

*0.0205

*0.0002

* p-values < 0.05

Influence of μa and μs’ variations on DCS flow index. Percentage errors (not

absolute) are used to visualize the influences of the individual optical properties on flow
indices, defined by the following equations:
% Error μ a =

% Error μ s ' =

% Error D B =

μ a − mid − μ a − dynamic
μ a − dynamic
μ s ' − mid −μ s ' − dynamic
μ s ' − dynamic

x100%

(14)

x100%

(15)

D B − mid − D B − dynamic
D B − dynamic

x100%

(16)

The estimates for these errors are the assumed optical properties (middle-interval) and
subsequent DB-mid per interval. The true values are the averaged optical properties
measured by Imagent (dynamic) and subsequent DB-dynamic per interval. Resulting
percentage errors in DCS DB due to inaccurate estimations of optical properties are
overlaid for both wavelengths and experiments in Fig. 25. Note that errors in μa are
during μa variation and those in μs’ during μs’ variation. In agreement with results thus far
the μs’ shows a larger influence on DCS flow indices, as visible by the wider range of DB
percentage errors, than μa. The trends in errors for μa and μs’ with those in DB also differ.
Overestimation and underestimation of μa result in overestimation and underestimation in
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DCS DB. On the contrary, μs’ overestimation and underestimation lead to DB
underestimation and overestimation. Both wavelengths display analogous behavior and
are in good agreement.

Figure 25. DCS Flow Index Errors Due to Inaccurate Optical Property Estimations
Inaccurate estimations (percentage errors) of μa and μs’ result in corresponding percentage DB errors
between DB-dynamic and DB-mid for both wavelengths.
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3.4 Influence of Tissue Optical Properties on Head/Neck Tumor Blood Flow Index

Ten patients with head and neck tumors, measured for hemodynamic information,
have their DCS flow indices evaluated for optical property influences. The resulting
mean optical properties over patients are: μa (830 nm) = 0.12 ± 0.03 cm-1 and μs’ (830
nm) = 7.80 ± 2.64 cm-1. The means ± SD’s (error bars) of tumor μa and μs’ are shown in
Fig. 26 and 27, respectively. Red and blue dots denote the overall patient maximum and

minimum optical properties, respectively. Patient blood flow indices (αDB-dynamic, αDB-min,
αDB-mean, and αDB-max) along with percentage errors thereof (aside from αDB-dynamic) are
given in Fig. 28 and 29. Note that the assumption of α = 1 from phantom experiments is
no longer correct as the real tissue consists of both static and dynamic scatterers.
Diffusion coefficient percentage errors are calculated using Eq. 16 by replacing the
phantom study estimate, DB-mid, with the corresponding tumor study estimates αDB-min,
αDB-mean, and αDB-max. Also, the true flow index DB-dynamic, calculated using Imagent
measured optical properties, from the phantom study is replaced in Eq. 16 by the
equivalent tumor study true flow index, αDB-dynamic. This produces percentage errors for
each flow index estimate for each patient (see Fig. 29).
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Figure 26. Tumor μa at 830 nm
Imagent measured μa, shown as means ± SD’s, obtained at 830 nm from tumor region for 10 subjects with
head and neck tumors during tumor study. Large variations can be seen to exist between the 10 subjects.

Figure 27. Tumor μs' at 830 nm
Imagent measured μs’, shown as means ± SD’s, obtained at 830 nm from tumor region for 10 subjects with
head and neck tumors during tumor study. Similar to μa in Fig. 26, large variations also exist in μs’ between
the 10 subjects.
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Figure 28. Tumor Flow Indices at 854 nm
DCS flow indices measured by DCS, shown as means ± SD’s, obtained at 854 nm from tumor region for 10
subjects with head and neck tumors and calculated using 830 nm optical properties during tumor study.
Patients are listed in order of increasing αDB-dynamic (854 nm). The underestimation of optical properties
(αDB-min) overestimates the flow indices whereas overestimating optical properties (αDB-max) underestimates
flow indices. These trends agree with phantom study results of a larger influence from μs’.

Figure 29. Tumor Flow Index Errors
Percentage errors in DCS flow indices at 854 nm from tumor region for 10 subjects with head and neck
tumors. DCS flow indices αDB-min, αDB-mean, and αDB-max are considered estimates with αDB-dynamic as true
flow indices for patients. The errors are shown to increase substantially with inaccuracies in optical
properties (see Fig. 26 and 27).
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To ease identification of differences in patient DCS flow index trends using the
diverse optical properties sets, they are ordered by increasing αDB-dynamic (true flow
index). A black line denotes the true flow indices data. Note that the patient numbers
depicted represent indices for trend illustration and are not related to those corresponding
to the actual measurement sequence. After this ordering, trend changes when calculating
flow indices without the true optical properties can be viewed (Fig. 28). When the μa and
μs’ are inaccurately estimated (αDB-min, αDB-mean, and αDB-max), the trends do not agree
with the true flow index trend (αDB-dynamic). The αDB estimates result in a wide range of
percentage errors: αDB-min from -8.07 to 278.15%, αDB-mean from -39.48 to 149.01%, and
αDB-max from -70.26 to 22.59%. The tumor study data is consistent with expectations
from phantom study results with μs’ variation appearing to play a greater role than μa in
DCS flow index errors. From Fig. 28, the consequential overestimation and
underestimation of blood flow indices are opposite of those of μs’ variation, as seen in
Fig. 25.
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CHAPTER 4: DISCUSSION AND CONCLUSIONS

This chapter begins with discussion on the influences of μa and μs’ variations on DBEinstein

(Chapter 4.1). Findings related to measurement errors in μa, μs’ and DB-dynamic are

then examined (Chapter 4.2). Next, the flow index errors due to the assumption of optical
properties are discussed (Chapter 4.3). A comparison is then provided between the invivo tumor study data and phantom study results (Chapter 4.4). Finally, conclusions from

this study are given (Chapter 4.5).

4.1 μa and μs’ Variation Influences on DB-Einstein

The Brownian motion of spherical particles, DB-Einstein, from the Intralipid solution in
liquid phantoms is calculated from the Einstein-Stokes formula (Eq. 7). This movement is
calculated based on the liquid phantom temperature, spherical particle radius, and
viscosity. The temperature has only small variations during both phantom experiments
(see Table 1, Fig. 6, and Fig. 16), with CV < 1.1%. Due to the ~4.5 hour duration of each
experiment, a general increase in ambient and thus phantom temperature is expected.
This increase includes heat from running equipment within the small, confined room. The
particle radius is assumed to be relatively constant during both experiments, with
Intralipid provided from the same batch supply. Only minor variations in viscosity are
evident, with CV < 2.2% for both experiments (see Table 1, Fig. 5, and Fig. 15). These
variations may be the result of the viscometer sensitivity at measurements near the
bottom of its range (0.2 cP) and minor sample-to-sample variations. The Newtonian fluid
assumption is determined acceptable as the samples measured at three separate RPMs
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showed small variation. Because of the stability of viscosity and temperature
measurements as well as the assumed constant particle radius, DB-Einstein is also expected
to be constant. This is found to be the case as is seen in Fig. 7 and 17 and with CV <
2.2% for DB-Einstein from Table 1.
The addition of ink and Intralipid solutions during μa and μs’ variation, respectively,
are not parameters expected to contribute to variations in DB-Einstein. Ink solution should
have no particles undergoing Brownian motion. On the other hand, Intralipid solution
does contain particles undergoing Brownian motion, but this motion is not anticipated to
change during measurement. Additions of Intralipid provide more scatterers undergoing
Brownian motion, but the particle motion is equivalent for all. The ratio of moving to
total scatterers (α) should also remain unchanged (α = 1) given that only the dynamic
particles from Intralipid are scatterers. The viscosity of ink and Intralipid solution is, as
mentioned, primarily water and variations thereof should not result in changing the
phantom viscosity. Similarly, the ink and Intralipid solutions were at room temperature at
the time of the experiments, just as the liquid phantom, having little influence on
temperature variations. From Fig. 5-7, 9, 15-17, and 21 the liquid phantom optical
properties exhibit independence from viscosity, temperature and DB-Einstein. With the
optical property independence and DB-Einstein stability, it is therefore considered
reasonable to use as the true flow index for liquid phantom spherical particle motion.
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4.2 Measurement Errors of μa, μs’, and DB-dynamic

From Fig. 9, 11, 19, and 21 the utilization of ink and Intralipid solutions for
manipulating μa and μs’, respectively, is validated. The incremental addition of ink
solution results in a linear increase in measured μa with relative stability of μs’ at both
wavelengths, as expected. Similarly, Intralipid solution linearly increases only μs’ at both
wavelengths. These measured optical properties were also found to be in good agreement
with the spectrometer and Mie theory predictions. Variation patterns in Imagent optical
property measurements may have been influenced by calibration at the midpoint: μa (830
nm) = 0.125 cm-1, μs’ (830 nm) = 10 cm-1.
Measurement errors in μs’ were less than 6% (see Table 2) for both wavelengths and
experiments comparable to the literature using Mie theory estimation (see Chapter 2.7)
[61]. Overall, average measurement errors for μa/μs’ are minimal with less than 4%/6%
during μa/μs’ variations. Previous studies experienced measurement error levels in this
range as well using frequency-domain spatially resolved NIRS [47, 48]. In comparing
optical property measurement errors at 780 and 830 nm, significant differences were
determined for μa during μa variation and μs’ during μs’ variation. The detection accuracy
of the Imagent at separate wavelengths is most likely the cause of such significance. No
significant differences were found between DB-dynamic measurement errors at 785 and 830
nm. These DB-dynamic errors averaged less than 7%, comparable to those of optical
properties (less than 6%), for both wavelengths and experiments. This likeness implies
optical property influences on DCS DB.

52

4.3 Resulting DB Errors from Optical Property Assumptions

Inaccurate estimations of μa and μs’ both produced higher DB measurement errors
(DB-mid) than in comparison with the true measurements (DB-dynamic). From Table 2, DB-mid
errors were ~13% for μa variation, ~50% for μs’ variation, and only ~7% for DB-dynamic in
both cases. From Table 3, Student t-tests compliment this lack of resemblance between
measured and true DB by their significant differences. Comparisons between DB-mid errors
due to the influence of μa and μs’ variations further extend this conclusion to include that
μs’ is a greater contributor than μa. This is elicited by the higher DB-mid measurement
errors during μs’ variation (Table 2), great differences in calculated p-values (Table 3),
and larger range of DB percentage errors due to inaccurate estimations of μs’ (Fig. 25).
The phase shifts of light due to dynamic scatterers collectively induce the light speckle
fluctuations. As DCS flow indices are derived from these fluctuations it is expected that
errors be more exaggerated by inaccurate scattering estimations. Coupling much larger
scattering over absorption (i.e., μs’ >> μa) in the liquid phantoms and biological tissues
with the definition of K2 (see Eq. 3) and the μs’2 term further support is given to μs’
having more significance than μa. Wavelengths were not determined to be a decisive
parameter in DB measurement errors due to optical property assumptions. During both
experiments, no significant difference was found between DB-dynamic and DB-mid at 785 and
830 nm (Table 2) and their trends were nearly identical as seen in Fig. 25. Due to the
closeness of the wavelengths employed, more information may be exposed by choosing a
wider range.
Further disparity between the influences of μa and μs’ variations on DCS flow index
errors exists within their related trends (see Fig. 14, 24, and 25). Overestimated and
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underestimated μa produces overestimated and underestimated DB, respectively.
Conversely, overestimated and underestimated μs’ produces underestimated and
overestimated DB, respectively. By examination of the boundaries of our tested optical
property inaccuracies (Fig. 25), the largest expected deviations in DCS flow indices can
be estimated. Overestimating/underestimating μa by up to ~ +150%/-40% produced DB
percentage errors up to ~ +40%/-20%. Overestimating/underestimating μs’ by up to ~
+175%/-35% produced DB percentage errors up to ~ -80%/+110%. The phantom
properties chosen for calibration may have influence over the optical properties
estimation errors.

4.4 In-vivo Tumor Study Data in Comparison to Phantom Study Results

Optical property variations were large between the patients in the head and neck
tumor study (see Fig. 26 and 27). This scenario proves useful for analyzing real-tissue
implications of the phantom study results. The optical properties of patients covered: μa
(830 nm) from 0.07 to 0.16 cm-1 and μs’ (830 nm) from 5.35 to 13.1 cm-1. These
properties are within the same range as those tested in the phantom experiments. The
trends in αDB, resulting from calculations with the different optical property sets, are in
agreement with conclusions from the phantom study. Overestimating/underestimating the
μa and μs’ (using maximum and minimum) produce underestimation/overestimation of
the DCS flow index (αDB-max and αDB-min). Thus, the variations in μs’ appear to be the
greater factor in influencing αDB errors than that of μa. Depending on the optical
properties assumed, the errors in αDB ranged from ~ -70% up to ~ +280%. Comparisons
are also made between the estimated αDB (αDB-min, αDB-mean, and αDB-max) trends and the
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true (αDB-dynamic). It is apparent that inaccurate optical property assumptions will alter the
patient order based on increasing αDB and potentially any subsequent conclusions made
from this data. Invalid conclusions in similar studies may result from this lack of
consideration into optical property influences on DCS flow indices.

4.5 Conclusions

DCS technology has provided deep tissue blood flow measurements in an increasing
field of applications thanks to its noninvasive nature and fast data acquisition capabilities.
Increasing in concert with these developments are the necessities of ensuring the proper
operation and application of the technology. This includes investigating errors that are
potentially encountered in measurements, notably the assumption of constant optical
properties, μa and μs’. DCS measurements are described by the extension of light
scattering techniques into the diffusive regime of deep tissue, resulting in a correlation
diffusion equation. DCS blood flow indices stem from a solution to this equation which
includes the parameters of tissue μa and μs’. With the advent of a hybrid optical
instrument developed by our lab, we can now measure tissue optical properties and blood
flow simultaneously. By also incorporating liquid phantom creation techniques to control
simulated tissue optical properties and flow, investigation of optical property influences
on DCS flow indices is now possible. The Brownian diffusion coefficient produced by
the Einstein-Stokes formula for particles in liquid was found applicable and usable as the
true flow index in comparison to DCS flow indices. The particle motions in the liquid
phantoms were determined to be independent of variations in the optical properties.
Although inaccurate estimations of both μa and μs’ produced errors in DCS flow indices
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larger than that when using true values, μs’ was found to have a more substantial
influence. This influence was not identified as being dependent on wavelengths
employed. Therefore, the concurrent measurement of tissue optical properties and DCS
flow indices is required within studies encountering significant μa and μs’ variations to
accurately determine tissue blood flow. The examination of a head and neck tumor study
elucidate the possible consequences of ignoring the optical property variations in real
tissue measurements.
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CHAPTER 5: SUMMARY AND PERSPECTIVES

In summary of this research study, I have provided a quantified generalization of the
influences of inaccurate estimations in optical properties on diffuse correlation
spectroscopy blood flow measurements by means of liquid phantoms and in-vivo
analysis. The recent integration by our lab of the Imagent and dual-wavelength DCS
flow-oximeter into a hybrid instrument has enabled the ability to carry out this
investigation. The design and completion of this study included my contributions to
several facets of operation. These contributions consist of the unique phantom study
experimental design (Chapter 2.6), determination of ideal hybrid instrument setup
(Chapter 2.1 – 2.3), details of liquid phantom composition, measurement equipment and
facilitation into our lab (Chapter 2.5), incorporation of measurement errors utilizing
Brownian motion and theoretical predictions (Chapter 2.4), exemplification of
generalized DCS flow errors through real tissue tumor study analysis (Chapter 2.8), and
general methods of data analysis (Chapter 2.7). The results of this study have also been
peer reviewed and published [64].
The experimental design of this phantom study was found capable of adequately
evaluating the influences of the optical properties on DCS flow indices. The approach
taken in this study sought to minimize variations other than the optical properties. The
usage of our hybrid instrument performed as expected without requiring complex
modifications or alterations. This was an important facet as this instrument is a means of
avoidance into the errors posed by inaccurate optical property estimations. To further this
study, an alternative approach would be to analyze Eq. 1 and 3 and determine the
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influences of optical property variations with varying parameters, which may be the
subject of future work. However, it is expected that without the knowledge of tissue
optical properties such extensive quantification may not provide useful results.
The optimal hybrid instrument setup was determined from the following factors. It is
expected that DCS flow indices obtained at different wavelengths provide equivalent
flow information. To evaluate this aspect, 785 and 830 nm wavelengths were used.
Originally, a long coherence length CW NIRS 690 nm laser was attempted instead of 785
nm, but due to technical circumstances was unavailable for this study. Utilizing different
laser source wavelengths for both Imagent and DCS may extend the applicability of the
results since no wavelengths at the low end of the NIR range were successfully
incorporated (i.e., ~650 nm). The next factor of interest is maintaining an optimal SNR
for both the Imagent and DCS equipment. The gain for the Imagent PMT was set at as
high as possible (without saturation) from the initial phantoms and was not adjusted
during each experiment. The source-detector separations and fiber orientation of the
Imagent probe were fixed and not deemed necessary for modification. For the DCS
system, the detector fibers were bundled and set at an equivalent source-detector
separation of 1.5 cm. This distance was chosen due to its compliance with diffusion
theory and adequate SNR. The SNR was increased through the averaging of the signal
from the four detectors. The range of optical properties chosen also may affect the SNR
and will be described shortly. The correlation time of DCS was found to be adequate in
detecting the motion of Intralipid particles during both μa and μs’ variations. The Imagent
averaged 10 data acquisitions per one frame and DCS about 25 per frame (at both
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wavelengths). These averaging parameters were determined to provide sufficiently stable
measurements from the hybrid instrument.
There are several options currently available for creating tissue-like phantoms for
NIR optical experimentation. Liquid phantoms were chosen over solid phantoms as they
are typically easier to create and manipulate. In addition, there is no inherent flow in solid
phantoms which would require additional design considerations. The liquid phantoms
comprised of Intralipid, distilled water, and India ink proved capable of our needs thanks
to their simplicity and versatility. For future studies, modifications to the liquid phantom
flow can be induced using methyl cellulose or glycerin to evaluate optical property
influences at different absolute DCS flow indices. However, the addition of these
elements may have the undesirable effect of also altering the phantom viscosity and
optical properties. The constituents were readily accessible without significant overhead
and cost with Intralipid requiring the most effort to obtain. To maintain adequate SNR,
the optical property ranges in this study were limited. More expansive ranges were tested
but produced unreliable and unstable results. In the future, creating liquid phantoms with
a broader range of μa and μs’ can test the expansion of current conclusions to a greater
variety of tissue types. The container size (aquarium) was chosen for adequate distance
from the probe to the sides such that small variations in position did not result in
interference due to boundaries. The custom probe holder was designed and put into a
schematic prior to machining by the University of Kentucky machine shop. It was
designed to be incorporated with the lab stand available providing stability and axial and
longitudinal positioning.
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Measurement errors for the DCS and Imagent were determined based on previous
studies to differentiate actual optical property influences on DCS flow indices and those
resulting from other factors. This includes the liquid phantom preparations and
measurement variations. The methods for expected value predictions were advantageous
in that they have already been discussed and used elsewhere allowing for quick
implementation into our experimental design. Brownian motion for spherical particles in
liquid is used for comparison with DCS. Spectrometer and Mie theory are used for
comparison with the Imagent measurements. The measurements of viscosity and
temperature related to Brownian motion required testing several apparatus setups. For
viscosity, a spindle viscometer was tested but had inadequate range due to the low
viscosity of distilled water, India ink, and Intralipid solutions. A cone-plate viscometer
with better low viscosity accuracy was purchased and performed adequately. No
continuous viscosity data could be acquired due to the induced motion of pumping liquid
phantom solution through the viscometer. The current study employs all solutions and
liquid phantoms at ambient temperature. This method provided the most stable
temperature over other methods such as immersing the aquarium into a larger water filled
container temperature controlled by an immersion circulator. More than one spectrometer
was tested in the determination of the India ink absorption coefficient: a 96-well plate
reader (Biotek), Jaz (Ocean Optics), and the Beckman Coulter as reported. Results were
comparable between the three, but the Beckman Coulter device was chosen due to
availability and speed of usage.
The tumor study required analyzing the hybrid equipment already in usage for that
study and reasonably comparing it to the phantom study. There is inherently greater
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difficulty and complexity involved in in-vivo tissue optical property and flow
measurements. Multiple DCS source-detector separations and wavelengths were used for
the head and neck tumor measurements. To properly attribute the optical property
influences on DCS flow indices the depth chosen was matched as closely as possible to
that of the Imagent. Although the tissue is assumed homogeneous for the purposes of the
theoretical models used, the best agreement between regions probed by the two systems
was chosen. The optical properties of the patients were within the range used in the
phantom study and it is expected that these will be similar for other tissue types, but a
holistic representation is beyond the scope of this study and should be determined based
on the context. More variations in absolute DCS flow indices were expected due to
anatomical and other subject differences. The agreement with the phantom study results
provides further insight as to the applicability of the generalized results into in-vivo
measurements.
To facilitate data analysis, a custom Matlab program was written to calculate DCS
flow using various sets of optical properties and variations. Only those flows
incorporating dynamic and constant property sets were included in this paper. This was
done to simplify the analysis and provide a less complex, but more usable realization of
the results. Data had to be extracted from the different files produced by the DCS and
Imagent for processing. A robust program was written automating data analysis while
providing control such as wavelengths used, source detector separations and processing
methods (constant vs. dynamic optical properties). The creation of correlation curve
figures each frame requires significant hard drive space which should be considered if
saving is desirable. The method of analysis using averaged optical properties over the
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intervals was determined acceptable as exhibited by measurement stability. However, in
real tissue measurements, transient fluctuations in optical properties can occur and
averaged properties may not be applicable.

62

REFERENCES

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.

Durduran, T., et al., Diffuse optical measurement of blood flow in breast tumors.
Opt Lett, 2005. 30(21): p. 2915-7.
Sunar, U., et al., Noninvasive diffuse optical measurement of blood flow and
blood oxygenation for monitoring radiation therapy in patients with head and
neck tumors: a pilot study. J Biomed Opt, 2006. 11(6): p. 064021.
Yu, G., et al., Intraoperative evaluation of revascularization effect on ischemic
muscle hemodynamics using near-infrared diffuse optical spectroscopies. J
Biomed Opt, 2011. 16(2): p. 027004.
Yu, G., et al., Noninvasive monitoring of murine tumor blood flow during and
after photodynamic therapy provides early assessment of therapeutic efficacy.
Clin Cancer Res, 2005. 11(9): p. 3543-52.
Li, J., et al., Noninvasive detection of functional brain activity with near-infrared
diffusing-wave spectroscopy. J Biomed Opt, 2005. 10(4): p. 44002.
Ubbink, D.T., et al., Skin microcirculation in diabetic and non-diabetic patients at
different stages of lower limb ischaemia. Eur J Vasc Surg, 1993. 7(6): p. 659-6.
Wahlberg, E., et al., Level of arterial obstruction in patients with peripheral
arterial occlusive disease (PAOD) determined by laser Doppler fluxmetry. Eur J
Vasc Surg, 1993. 7(6): p. 684-9.
Bonner, R. and R. Nossal, Model for laser Doppler measurements of blood flow
in tissue. Appl Opt, 1981. 20: p. 2097-2107.
Wang, R.K. and L. An, Doppler optical micro-angiography for volumetric
imaging of vascular perfusion in vivo. Opt Express, 2009. 17(11): p. 8926-40.
Chen, Z., et al., Optical Doppler tomographic imaging of fluid flow velocity in
highly scattering media. Opt Lett, 1997. 22(1): p. 64-6.
Li, L., et al., Three-dimensional combined photoacoustic and optical coherence
microscopy for in vivo microcirculation studies. Opt Express, 2009. 17(19): p.
16450-5.
Durduran, T., Non-invasive measurements of tissue hemodynamics with hybrid
diffuse optical methods. 2004, University of Pennsylvania, Dissertation.
Zhou, C., In-vivo optical imaging and spectroscopy of cerebral hemodynamics.
2007, University of Pennsylvania, Dissertation.
Boas, D.A., Diffuse photon probes of structural and dynamical properties of
turbid media: Theory and biomedical applications. 1996, University of
Pennsylvania, Dissertation.
Boas, D.A. and A.G. Yodh, Spatially varying dynamical properties of turbid
media probed with diffusing temporal light correlation. J Opt Soc Am A Opt
Image Sci Vis, 1997. 14(1): p. 192-215.
Xu, R., Particle Characterization: Light Scattering Methods. Particle Technology
Series, ed. B. Scarlett. 2000, Netherlands: Kluwer Academic Publishers. 397.
Boas, D.A., L.E. Campbell, and A.G. Yodh, Scattering and imaging with
diffusing temporal field correlations. Phys Rev Lett, 1995. 75(9): p. 1855-1858.
Cheung, C., et al., In vivo cerebrovascular measurement combining diffuse nearinfrared absorption and correlation spectroscopies. Phys Med Biol, 2001. 46(8):
p. 2053-2065.
63

19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.

Jaillon, F., et al., Activity of the human visual cortex measured non-invasively by
diffusing-wave spectroscopy. Opt Express, 2007. 15(11): p. 6643-6650.
Buckley, E.M., et al., Cerebral hemodynamics in preterm infants during
positional intervention measured with diffuse correlation spectroscopy and
transcranial Doppler ultrasound. Opt Express, 2009. 17(15): p. 12571-81.
Roche-Labarbe, N., et al., Noninvasive optical measures of CBV, StO(2), CBF
index, and rCMRO(2) in human premature neonates' brains in the first six weeks
of life. Hum Brain Mapp, 2010. 31(3): p. 341-52.
Menon, C., et al., An integrated approach to measuring tumor oxygen status using
human melanoma xenografts as a model. Cancer Res, 2003. 63(21): p. 72327240.
Kim, M.N., et al., Noninvasive measurement of cerebral blood flow and blood
oxygenation using near-infrared and diffuse correlation spectroscopies in
critically brain-injured adults. Neurocrit Care, 2010. 12(2): p. 173-80.
Zhou, C., et al., Diffuse optical monitoring of hemodynamic changes in piglet
brain with closed head injury. J Biomed Opt, 2009. 14(3): p. 034015.
Durduran, T., et al., Diffuse optical measurement of blood flow, blood
oxygenation, and metabolism in a human brain during sensorimotor cortex
activation. Opt Lett, 2004. 29(15): p. 1766-8.
Culver, J.P., et al., Diffuse optical tomography of cerebral blood flow,
oxygenation, and metabolism in rat during focal ischemia. J Cereb Blood Flow
Metab, 2003. 23(8): p. 911-924.
Li, J., et al., Transient functional blood flow change in the human brain measured
noninvasively by diffusing-wave spectroscopy. Opt Lett, 2008. 33(19): p. 2233-5.
Zhou, C., et al., Diffuse optical monitoring of blood flow and oxygenation in
human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed
Opt, 2007. 12(5): p. 051903.
Zhou, C., et al., Diffuse optical correlation tomography of cerebral blood flow
during cortical spreading depression in rat brain. Opt Express, 2006. 14: p. 11251144.
Busch, T.M., et al., Fluence rate-dependent intratumor heterogeneity in
physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Photochem Photobiol Sci, 2009. 8(12): p. 1683-1693.
Sunar, U., et al., Hemodynamic responses to antivascular therapy and ionizing
radiation assessed by diffuse optical spectroscopies. Opt Express, 2007. 15(23):
p. 15507-15516.
Yu, G., et al., Real-time in situ monitoring of human prostate photodynamic
therapy with diffuse light. Photochem Photobiol, 2006. 82(5): p. 1279-84.
Durduran, T., et al., Optical measurement of cerebral hemodynamics and oxygen
metabolism in neonates with congenital heart defects. J Biomed Opt, 2010. 15(3):
p. 037004.
Koban, L., et al., Processing of emotional words measured simultaneously with
steady-state visually evoked potentials and near-infrared diffusing-wave
spectroscopy. BMC Neurosci, 2010. 11: p. 85.
Edlow, B.L., et al., The effects of healthy aging on cerebral hemodynamic
responses to posture change. Physiol Meas, 2010. 31(4): p. 477-95.

64

36.
37.
38.

39.
40.
41.

Durduran, T., et al., Transcranial optical monitoring of cerebrovascular
hemodynamics in acute stroke patients. Opt Express, 2009. 17(5): p. 3884-902.
Shang, Y., et al., Cerebral monitoring during carotid endarterectomy using nearinfrared diffuse optical spectroscopies and electroencephalogram. Phys Med
Biol, 2011. 56 p. 3015-3032.
Ninck, M., M. Untenberger, and T. Gisler, Diffusing-wave spectroscopy with
dynamic contrast variation: disentangling the effects of blood flow and
extravascular tissue shearing on signals from deep tissue. Biomed Opt Express,
2010. 1(5): p. 1502-1513.
Belau, M., et al., Noninvasive observation of skeletal muscle contraction using
near-infrared time-resolved reflectance and diffusing-wave spectroscopy. J
Biomed Opt, 2010. 15(5): p. 057007.
Shang, Y., et al., Effects of muscle fiber motion on diffuse correlation
spectroscopy blood flow measurements during exercise. Biomed Opt Express,
2010. 1(2): p. 500-511.
Yu, G., et al., Validation of diffuse correlation spectroscopy for muscle blood flow
with concurrent arterial spin labeled perfusion MRI. Opt Express, 2007. 15(3): p.
1064-1075

42.
43.
44.
45.
46.
47.
48.
49.
50.

51.

Dietsche, G., et al., Fiber-based multispeckle detection for time-resolved
diffusing-wave spectroscopy: characterization and application to blood flow
detection in deep tissue. Appl Opt, 2007. 46(35): p. 8506-14.
Yu, G., et al., Time-dependent blood flow and oxygenation in human skeletal
muscles measured with noninvasive near-infrared diffuse optical spectroscopies. J
Biomed Opt, 2005. 10(2): p. 024027.
Shang, Y., et al., Portable optical tissue flow oximeter based on diffuse
correlation spectroscopy. Opt Lett, 2009. 34(22): p. 3556-8.
Mesquita, R.C., et al., Hemodynamic and metabolic diffuse optical monitoring in
a mouse model of hindlimb ischemia. Biomed Opt Express, 2010. 1(4): p. 11731187.
Peskir, G., On the diffusion coefficient: The Einstein relation and beyond. Stoch
Models, 2003. 19(3): p. 383-405.
Wallace, D., et al. Summary of the results of a 95 subject human clinical trial for
the diagnosis of peripheral vascular disease using a near infrared frequency
domain hemoglobin spectrometer. in Proc. of SPIE. 1999.
Fantini, S., M.A. Franceschini, and E. Gratton, Semi-infinite-geometry boundaryproblem for light migration in highly scattering media - a frequency-domain study
in the diffusion-approximation. J Opt Soc Am B, 1994. 11(10): p. 2128-2138.
Jaillon, F., et al., Diffusing-wave spectroscopy from head-like tissue phantoms:
influence of a non-scattering layer. Opt Express, 2006. 14(22): p. 10181-94.
Culver, J.P., et al., Three-dimensional diffuse optical tomography in the parallel
plane transmission geometry: Evaluation of a hybrid frequency
domain/continuous wave clinical system for breast imaging. Med Phys, 2003.
30(2): p. 235-247.
Boas, D.A., et al., Three dimensional Monte Carlo code for photon migration
through complex heterogeneous media including the adult human head. Opt
Express, 2002. 10(3): p. 159-170.

65

52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.

Gagnon, L., et al., Investigation of diffuse correlation spectroscopy in multilayered media including the human head. Opt Express, 2008. 16(20): p. 1551430.
Kim, J.G. and H. Liu, Investigation of biphasic tumor oxygen dynamics induced
by hyperoxic gas intervention: the dynamic phantom approach. Appl Opt, 2008.
47(2): p. 242-52.
Rice, S.O., Mathematical analysis of random noise, in Noise and Stochastic
Processes, N. Wax, Editor. 1954, Dover: New York. p. 133.
Walker, S.A., S. Fantini, and E. Gratton. Effect of index of refraction mismatch on
the recovery of optical properties of cylindrical inhomogeneities in an infinite
turbid medium. in Proc. of SPIE. 1997.
Li, X., Fluorescence and diffusive wave diffraction tomographic probes in turbid
media. 1998, University of Pennsylvania, Dissertation.
Hueber, D., et al. New optical probe designs for absolute (self-calibrating) NIR
tissue hemoglobin measurements. in Proc. of SPIE. 1999.
EngineeringToolBox. Unit Converter with the most Common Units. Available
from: http://www.engineeringtoolbox.com/unit-converter-d_185.html.
Choe, R., Diffuse optical tomography and spectroscopy of breast cancer and fetal
brain. 2005, University of Pennsylvania, Dissertation.
Prahl, S.A. Optical properties spectra. Available from:
http://omlc.ogi.edu/spectra/index.html.
van Staveren, H.J., et al., Light scattering in Intralipid-10% in the wavelength
range of 400-1100 nm. Appl Opt, 1991. 30: p. 4507-4514.
Fantini, S., et al., Quantitative determination of the absorption spectra of
chromophores in strongly scattering media: a light-emitting-diode based
technique. Appl Opt, 1994. 33(22): p. 5204-13.
Spichtig, S., et al., Multifrequency frequency-domain spectrometer for tissue
analysis. Rev Sci Instrum, 2009. 80(2): p. 024301.
Irwin, D., et al., Influences of tissue absorption and scattering on diffuse
correlation spectroscopy blood flow measurements. Biomed Opt Express, 2011.
2(7): p. 1969-1985.

66

VITA

DATE & PLACE OF BIRTH
June 15, 1980 in Louisville, KY
EDUCATION
University of Louisville, Louisville, KY
Bachelor of Science in Computer Engineering
and Computer Science

2008

PROFESSIONAL POSITIONS
University of Kentucky Center for Biomedical Engineering
Biophotonics Laboratory
Lexington, KY
Research Assistant

2009 – Present

SCHOLASTICS & PROFESSIONAL HONORS
Student Travel Support, University of Kentucky

2011

PUBLICATIONS
D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, and G. Yu,
Influences of tissue absorption and scattering on diffuse correlation spectroscopy
blood flow measurements. Biomed Opt Express, 2011. 2(7): p. 1969-1985.
Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, and G. Yu, Portable optical tissue
flow oximeter based on diffuse correlation spectroscopy. Opt Lett, 2009. 34(22): p.
3556-8.
PRESENTATIONS/ABSTRACTS in CONFERENCES/PROCEEDINGS
D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, and G. Yu,
“Influences of tissue absorption and scattering on diffuse correlation spectroscopy
blood flow measurements in head and neck tumors”, in 2011 Advances in Optics for
Biotechnology, Medicine and Surgery XII, ECI Conferences, Naples, FL, USA
(2011)
D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, and G. Yu,
“Influences of tissue absorption and scattering on diffuse correlation spectroscopy
blood flow measurements in head and neck tumors”, in 2011 Markey Cancer Center
Research Day, University of Kentucky (2011)
Y. Shang, R. Cheng, L. Dong, D. Irwin, K. M. Gurley, K. R. Swartz, S. S. Salles, and
G. Yu, “Evaluation of electronic stimulation impact on muscle hemodynamics using
diffuse optical spectroscopies”, 23rd Annual Physical Medicine and Rehabilitation
Research Day, Lexington, KY, USA (2011)

67

Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, K. R. Swartz, S. S. Salles, and G.
Yu, “Diffuse optical spectroscopies for evaluation of muscle hemodynamic
enhancements by electrical stimulation”, in 2010 Biomedical Optics and 3-D
Imaging, OSA Optics & Photonics Congress, Miami, FL, USA (2010)
Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, K. R. Swartz, S. S. Salles, and G.
Yu, “Diffuse optical spectroscopies for evaluation of muscle hemodynamic
enhancements by electrical stimulation”, UK Muscle Biology Fall Retreat, Lexington,
KY, USA (2010)
G. Yu, Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, and S. P. Saha, “Portable
optical tissue flow oximeter for evaluation of revascularization effect on ischemic
muscle hemodynamics”, in 2010 Biomedical Optics and 3-D Imaging, OSA Optics &
Photonics Congress, Miami, FL, USA (2010)
G. Yu, Y. Zhao, R. Cheng, L. Dong, and D. Irwin, “A portable optical tissue flowoximeter based on diffuse correlation spectroscopy”, in BiOS SPIE Photonics West.
San Francisco, CA, USA (2010)
Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles, and G.
Yu, “Noninvasive assessment of muscle hemodynamic enhancement by electrical
stimulation using diffuse optical spectroscopies”, Fall Annual Meeting of the
Biomedical Engineering Society, Pittsburgh, PA, USA (2009)
G. Yu, Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, and S. S.
Salles, “Diffuse optical evaluation of muscle hemodynamic responses to electrical
stimulation”, 2nd Photonics and OptoElectronics Meetings (POEM 2009), Wuhan,
China (2009)
Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles, and G.
Yu, “Noninvasive assessment of muscle hemodynamic enhancement by electrical
stimulation using diffuse optical spectroscopies”, Adult Skeletal Muscle Symposium:
Clinical Problems, Molecular Targets, University of Kentucky (2009)
Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles, and G.
Yu, “Noninvasive assessment of muscle hemodynamic enhancement by electrical
stimulation using diffuse optical spectroscopies”, UK Linda and Jack Gill Heart
Institute Cardiovascular Research Day, University of Kentucky (2009)
TYPED NAME
Daniel A. Irwin

68

